Skip to main content
NCBI home page
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 1983 Jun;9(2):80–84. doi: 10.1136/jme.9.2.80

Basic problems in controlled trials.

R Burkhardt, G Kienle
PMCID: PMC1059346  PMID: 6876102

Abstract

On the basis of critical discussions which have taken place in recent years in the Federal Republic of Germany, certain methodological, ethical and legal problems arising in relation to controlled trials are discussed. Because of methodological inconsistencies inherent in the experimental approach, the efficacy of a drug must in any case be judged by physicians. This leads to major ethical and even--at least in Germany--legal problems which impose considerable limits on the feasibility of controlled trials in Germany. Editor's note: This paper is written at the invitation of the journal, following the considerable controversy on the ethics of clinical trials in the European Journal of Clinical Pharmacology (8-11). A critical commentary follows the paper with a short response from the authors and a further response from the commentator.

Full text

PDF
80

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burkhardt R., Kienle G. Controlled trials - a social challenge. Comments on a recent controversy. Eur J Clin Pharmacol. 1981;20(4):311–319. doi: 10.1007/BF00618783. [DOI] [PubMed] [Google Scholar]
  2. Burkhardt Rainer, Kienle Gerhard. Controlled clinical trials and medical ethics. Lancet. 1978 Dec 23;2(8104-8105):1356–1359. [PubMed] [Google Scholar]
  3. Cassileth B. R., Zupkis R. V., Sutton-Smith K., March V. Informed consent -- why are its goals imperfectly realized? N Engl J Med. 1980 Apr 17;302(16):896–900. doi: 10.1056/NEJM198004173021605. [DOI] [PubMed] [Google Scholar]
  4. Chalmers T. C., Block J. B., Lee S. Controlled studies in clinical cancer research. N Engl J Med. 1972 Jul 13;287(2):75–78. doi: 10.1056/NEJM197207132870205. [DOI] [PubMed] [Google Scholar]
  5. HILL A. B. Medical ethics and controlled trials. Br Med J. 1963 Apr 20;1(5337):1043–1049. doi: 10.1136/bmj.1.5337.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Herbert Victor. Informed consent--a legal evaluation. Cancer. 1980 Aug 15;46(4):1042–1044. [PubMed] [Google Scholar]
  7. Hittner H. M., Godio L. B., Rudolph A. J., Adams J. M., Garcia-Prats J. A., Friedman Z., Kautz J. A., Monaco W. A. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med. 1981 Dec 3;305(23):1365–1371. doi: 10.1056/NEJM198112033052301. [DOI] [PubMed] [Google Scholar]
  8. Ingelfinger F. J. Informed (but uneducated) consent. N Engl J Med. 1972 Aug 31;287(9):465–466. doi: 10.1056/NEJM197208312870912. [DOI] [PubMed] [Google Scholar]
  9. Jesdinsky H. J. Randomized controlled trials and society. Eur J Clin Pharmacol. 1981;20(4):235–236. doi: 10.1007/BF00618770. [DOI] [PubMed] [Google Scholar]
  10. Kathe B. A., Chan Y. K., Buehler D. A., Evans J. H., Fehm P. Protection of patient rights and welfare in the VA cooperative studies program. Control Clin Trials. 1981 Dec;2(4):267–274. doi: 10.1016/0197-2456(81)90017-9. [DOI] [PubMed] [Google Scholar]
  11. Koller S. Angriff auf den Fortschritt der Medizin Behauptung der Strafbarkeit kontrollierter klinischer Therapieversuche. Fortschr Med. 1977 Nov 10;95(42):2570–2574. [PubMed] [Google Scholar]
  12. Laforet E. G. The fiction of informed consent. JAMA. 1976 Apr 12;235(15):1579–1584. [PubMed] [Google Scholar]
  13. Lasagna L. Placebos and controlled trials under attack. Eur J Clin Pharmacol. 1979 Jul;15(6):373–374. doi: 10.1007/BF00561733. [DOI] [PubMed] [Google Scholar]
  14. Lee K. L., McNeer J. F., Starmer C. F., Harris P. J., Rosati R. A. Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease. Circulation. 1980 Mar;61(3):508–515. doi: 10.1161/01.cir.61.3.508. [DOI] [PubMed] [Google Scholar]
  15. Meier P. Statistics and medical experimentation. Biometrics. 1975 Jun;31(2):511–529. [PubMed] [Google Scholar]
  16. Meier P. Terminating a trial -- the ethical problem. Clin Pharmacol Ther. 1979 May;25(5 Pt 2):633–640. doi: 10.1002/cpt1979255part2633. [DOI] [PubMed] [Google Scholar]
  17. Peto R. Clinical trial methodology. Biomedicine. 1978 Sep;28(Spec No):24–36. [PubMed] [Google Scholar]
  18. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Weiter J. J. Retrolental fibroplasia: an unsolved problem. N Engl J Med. 1981 Dec 3;305(23):1404–1406. doi: 10.1056/NEJM198112033052309. [DOI] [PubMed] [Google Scholar]
  20. Wilhelmsen L. Ethics of clinical trials -- the use of placebo. Eur J Clin Pharmacol. 1979 Nov;16(5):295–297. doi: 10.1007/BF00605624. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES